How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,247 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Preliminary Evaluation of a Web-Based Psychological Screening Tool in Adolescents Undergoing Minimally Invasive Pectus Surgery: Single-Center Observational Cohort Study Full Text available with Trip Pro

Preliminary Evaluation of a Web-Based Psychological Screening Tool in Adolescents Undergoing Minimally Invasive Pectus Surgery: Single-Center Observational Cohort Study Preoperative anxiety and depression are predominant risk factors for increased postoperative pain. Thoracic wall deformities in adolescents often cause low self-esteem, which contributes to psychological concerns. Several studies have suggested a relationship between preoperative mental health support and enhanced recovery after (...) surgery.This study investigated the validity of screening questionnaires concerning psychological trait and state characteristics via a patient-specific online platform.Patients scheduled for elective pectus surgery between June 2017 and August 2017 were invited to participate in clinical interviews and online self-report questionnaires. All patients were recruited in the Anesthesiology Department, Antwerp University Hospital, Belgium. This single-center observational cohort study was performed

2018 JMIR mental health

102. Frailty and nutritional status in older people: the Mini Nutritional Assessment as a screening tool for the identification of frail subjects Full Text available with Trip Pro

Frailty and nutritional status in older people: the Mini Nutritional Assessment as a screening tool for the identification of frail subjects Frailty is a condition characterized by reduced resistance to low-level stress events, resulting from the progressive decline of multiple physiological systems observed with aging. Many factors can contribute to the pathogenesis of frailty, and nutritional status appears to play a key role. The objective of the study was to investigate the relationship (...) of Daily Living (ADL), Instrumental Activity of Daily Living (IADL), Mini-Mental State Examination (MMSE), Geriatric Depression Scale (GDS), and MNA. Comorbidity was assessed using the Cumulative Illness Rating Scale for Geriatrics (CIRS-G). Muscle strength was measured by handgrip dynamometry, and frailty score was calculated using the Survey of Health, Ageing and Retirement in Europe-Frailty Index (SHARE-FI).Approximately 38% of the study population was frail, with the prevalence of frailty being

2018 Clinical interventions in aging

103. Implementation of the STarT Back Screening Tool

Implementation of the STarT Back Screening Tool Implementation of the STarT Back Screening Tool - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Implementation of the STarT Back Screening Tool The safety (...) by (Responsible Party): Luciola da Cunha Menezes Costa, Universidade Cidade de Sao Paulo Study Details Study Description Go to Brief Summary: The STarT Back Screening Tool (SBST) has been used in different healthcare settings in order to stratify the management of patients with low back pain. However, to date, no study has investigated the feasibility of implementing the SBST in emergency departments. The objective of this study will be to test the implementation of the SBST in the stratification of patients

2018 Clinical Trials

104. Implementing a Digital Child Mental Health Screening, Literacy, and Management Tool in Faith-Based Settings

Implementing a Digital Child Mental Health Screening, Literacy, and Management Tool in Faith-Based Settings Implementing a Digital Child Mental Health Screening, Literacy, and Management Tool in Faith-Based Settings - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Implementing a Digital Child Mental Health Screening, Literacy, and Management Tool in Faith-Based Settings The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier

2018 Clinical Trials

105. Depression Screening in Primary Care: Using HIT for Patients With Limited English

Depression Screening in Primary Care: Using HIT for Patients With Limited English Depression Screening in Primary Care: Using HIT for Patients With Limited English - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Depression Screening in Primary Care: Using HIT for Patients With Limited English The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03191929 Recruitment Status : Completed First Posted : June 19, 2017 Last Update Posted : August 27, 2018 Sponsor: Dara Sorkin Information provided by (Responsible

2017 Clinical Trials

106. Screening for depression in hospitalized medical patients. Full Text available with Trip Pro

that tested the performance of depression screening tools in inpatient settings and studies that examined associations between depression detected during hospitalization and clinical or utilization outcomes. Two investigators reviewed each full-text article and extracted data. The prevalence of depression ranged from 5% to 60%, with a median of 33%, among hospitalized patients. Several screening tools identified showed high sensitivity and specificity, even when self-administered by patients or when (...) Screening for depression in hospitalized medical patients. Depression among hospitalized patients is often unrecognized, undiagnosed, and therefore untreated. Little is known about the feasibility of screening for depression during hospitalization, or whether depression is associated with poorer outcomes, longer hospital stays, and higher readmission rates. We searched PubMed and PsycINFO for published, peer-reviewed articles in English (1990-2016) using search terms designed to capture studies

2017 Journal of Hospital Medicine

107. Infertile women who screen positive for depression are less likely to initiate fertility treatments. Full Text available with Trip Pro

disorders and to evaluate their perception of mental health disorders on infertility.Of 959 surveys sent, 416 women completed the questionnaire (43%). The prevalence screening positive for depression, using the NIH PROMIS screening tool, was 41%. Sixty-two percent of all women initiated infertility treatment, and of these, 81% did so within 4 months. In multivariate analysis, women who screened positive for depression had 0.55 times the odds of initiating treatment for infertility (95% CI: 0.31-0.95 (...) Infertile women who screen positive for depression are less likely to initiate fertility treatments. Are infertile women who screen positive for depression less likely to initiate infertility treatments?Infertile women who screen positive for depression are less likely to initiate treatment for infertility.Infertility imposes a psychological burden on many couples. Depression and anxiety have been demonstrated in ~40% of infertile women, which is twice that of fertile women. Further

2017 Human Reproduction

108. Two-Step Screening for Depressive Symptoms and Prediction of Mortality in Patients With Heart Failure. Full Text available with Trip Pro

for predicting poor prognosis in heart failure than is either the 2-item or the 9-item tool alone is not known.To determine whether the 2-step method is better than either the 2-item or the 9-item questionnaire alone for predicting all-cause mortality in heart failure.During a 2-year period, 562 patients with heart failure were assessed for depression by using the 2-step method. With the 2-step method, results are considered positive if patients endorse either depressed mood or anhedonia on the 2-item screen (...) Two-Step Screening for Depressive Symptoms and Prediction of Mortality in Patients With Heart Failure. Comorbid depression in patients with heart failure is associated with increased risk for death. In order to effectively identify depressed patients with cardiac disease, the American Heart Association suggests a 2-step screening method: administering the 2-item Patient Health Questionnaire first and then the 9-item Patient Health Questionnaire. However, whether the 2-step method is better

2017 American Journal of Critical Care

109. Depression Outcomes in Adults Attending Family Practice Were Not Improved by Screening, Stepped-Care, or Online CBT during a 12-Week Study when Compared to Controls in a Randomized Trial. Full Text available with Trip Pro

decreased from 15.3 ± 3.6 to 5.4 ± 2.8 (p < 0.05). In conclusion, these findings from this controlled randomized study do not suggest that using depression screening tools in family practice improves outcomes. They also suggest that much of the depression seen in primary care spontaneously resolves and do not support suggestions that more complex treatment programs or pathways improve depression outcomes in primary care. Replication studies are required due to study limitations. (...) Depression Outcomes in Adults Attending Family Practice Were Not Improved by Screening, Stepped-Care, or Online CBT during a 12-Week Study when Compared to Controls in a Randomized Trial. There is uncertainty regarding possible benefits of screening for depression in family practice, as well as the most effective treatment approach when depression is identified. Here, we examined whether screening patients for depression in primary care, and then treating them with different modalities

2017 Frontiers in Psychiatry Controlled trial quality: uncertain

110. Screening of depression in cardiology: A study on 617 cardiovascular patients. Full Text available with Trip Pro

Screening of depression in cardiology: A study on 617 cardiovascular patients. Depression screening in the cardiovascular disease (CVD) care setting is under-performed, also because the issue of the optimal screening tools cut-off is still open. We analysed which HADS (Hospital Anxiety and Depression Scale) total score cut-off value shows the best properties in two groups of 357 Acute Coronary Syndrome (ACS) and 260 Chronic Coronary Artery Disease (CAD) hospitalized patients.A Receiver (...) in both groups, with high negative predicted values (95.5% and 92.4%, respectively).Using a cut-off value of 14, the HADS could be considered a good screening tool to identify hospitalized CAD and ACS patients requiring a more accurate depression assessment, in order to promptly plan the most appropriate treatment strategies and prevent the negative effects of depression in CVD patients.Copyright © 2017 Elsevier B.V. All rights reserved.

2017 International journal of cardiology

111. Validity and Utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross‐Sectional Study Full Text available with Trip Pro

80.00%, specificity 86.88%, area under receiver operating characteristic curve = 0.89; 95% confidence interval [0.84, 0.94]).The PHQ-2 and PHQ-9 demonstrated good psychometric properties, suggesting their potential benefit as tools for depression screening and diagnosis in rural, Spanish-speaking populations.© 2017 The Authors. Journal of Clinical Psychology published by Wiley Periodicals, Inc. (...) Validity and Utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross‐Sectional Study Depressive disorders are frequently under diagnosed in resource-limited settings because of lack of access to mental health care or the inability of healthcare providers to recognize them. The Patient Health Questionnaire (PHQ)-2 and the PHQ-9 have been widely used for screening and diagnosis of depression in primary care

2017 Journal of clinical psychology

112. Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for it Full Text available with Trip Pro

Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for it To provide an overview of the epidemiology of depression in chronic neurologic conditions that can affect individuals throughout the lifespan (epilepsy, migraine, multiple sclerosis [MS]) and examine depression screening tools for adults with these conditions.Depression is common in neurologic conditions and can be associated with lower quality of life, higher health resource utilization, and poor (...) adherence to treatment. It affects around 20%-30% of those with epilepsy, migraine, and MS, and evidence for a bidirectional association exists for each of these conditions. Depression screening tools generally perform well in neurologic conditions, but are not without limitations.Depression is a major contributor to poor outcomes in epilepsy, migraine, and MS. Although psychiatric resources are scarce globally, this is no reason to ignore depression in neurologic conditions. Depression screening tools

2017 Neurology: Clinical Practice

113. Screening and Counselling for Alcohol Consumption During Pregnancy

, and Evaluation (GRADE) methodology framework. Benefits, Harms, Costs Implementation of the recommendations in these guidelines using validated screening tools and brief intervention approaches may increase obstetrical care provider recognition of alcohol consumption and problematic alcohol use among women of child-bearing age and those who are pregnant. It is anticipated that health care providers will become confident and competent in managing and supporting these women so they can achieve optimal health (...) (in a nonjudgmental way) to determine use. If women consume alcohol, one of the following screening tools should be used: AUDIT-C or T-ACE, or another evidence-based screening tool available in the provincial/territorial prenatal record. If women consume alcohol, pattern of use should be established to screen for binge drinking (strong, high). 2 If screening identifies an alcohol use disorder, brief intervention should be provided at the same time screening is completed (strong, high). 3 When a maternal alcohol

2020 Society of Obstetricians and Gynaecologists of Canada

114. Prevention and early intervention for adults with mild to moderate depression

Prevention and early intervention for adults with mild to moderate depression Prevention and early intervention for adults with mild to moderate depression d An Evidence Check rapid review brokered by the Sax Institute for Beyond Blue. December 2018. An Evidence Check rapid review brokered by the Sax Institute for Beyond Blue. December 2018. This report was prepared by: Frances Kay-Lambkin, Jayden Gilbert, Lauren Pedemont, Matthew Sunderland, Hazel Dalton, Tonelle Handley, Sally Chan, David (...) @saxinstitute.org.au Phone: +61 2 91889500 Suggested Citation: Kay-Lambkin F, Gilbert J, Pedemont L, Sunderland M, Dalton H et al. Prevention and early intervention for people aged 18 and over with, or at risk of, mild to moderate depression and anxiety: An Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for Beyond Blue, 2018. Disclaimer: This Evidence Check Review was produced using the Evidence Check methodology in response to specific questions from the commissioning agency

2018 Sax Institute Evidence Check

115. Depression

can cause motor retardation). complex care packages; many staff involved and lack of continuity. Assessment tools: A number of assessment tools are available. In primary care, the PHQ-9 can be used as a screening tool. The brief Edinburgh Depression Scale is suited to palliative care patients. The Hospital Anxiety and Depression questionnaire is widely available but focuses on physical symptoms so may be less helpful in this context. Management General In mild depression, psychological support can (...) cancers (more common). Additional barriers to diagnosis exist and include: patient/family feeling that a “fighting spirit” is needed to maximise active treatment/ support from health professionals. difficulty deciding whether depression is a primary problem or reflects suboptimal symptom control concerns about polypharmacy and drug interactions. other physical/ psychological conditions mimicking depression. exclude hypoactive exclude hypothyroidism screen for dementia review medication ( haloperidol

2018 Scottish Palliative Care Guidelines

116. Postnatal depression

symptoms in the postpartum period differs across cultures could improve detection and provide new insights into the pathogenesis. Moreover, it is a necessary step to evaluate the universal use of screening (...) instruments in research and clinical practice. In the current study we sought to assess whether the Edinburgh Postnatal Depression Scale (EPDS), the most widely used screening tool for postpartum depression , measures the same underlying construct across cultural groups in a large international (...) ). Diagnostic accuracy was similar in identifying any disorder (likelihood ratios 5.8 and 6). CONCLUSIONS: Endorsement of Whooley questions in pregnancy indicates the need for a clinical assessment of diagnosis and could be implemented when maternity professionals have been appropriately 2018 18. Study protocol on criterion validation of Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire (PHQ-9) and Centre for Epidemiological Studies- Depression (CES-D) screening tools among rural

2018 Trip Latest and Greatest

117. Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force. Full Text available with Trip Pro

) and searches of reference lists of published literature.Trials and recent systematic reviews of treatment, test-retest studies of screening, and trials and large cohort studies for harms.Data were abstracted by 1 investigator and checked by another; 2 investigators independently assessed study quality.Limited evidence from 5 studies showed that such tools as the Beck Depression Inventory and Patient Health Questionnaire for Adolescents had reasonable accuracy for identifying MDD among adolescents (...) outcomes of screening and treatment among children younger than 12 years.No evidence was found of a direct link between screening children and adolescents for MDD in primary care or similar settings and depression or other health-related outcomes. Evidence showed that some screening tools are accurate and some treatments are beneficial among adolescents (but not younger children), with no evidence of associated harms.Agency for Healthcare Research and Quality.

2016 Annals of Internal Medicine

118. Management of Major Depressive Disorder (2nd Ediiton)

in acute and continuation phase treatment of major depressive disorder. MAJOR DEPRESSIVE DISORDER IN PERINATAL WOMEN • Screening for perinatal depression may be done in a two-stage approach. ? Use brief screening tools e.g. Patient Health Questionnaire-2 or Whooley Questions in the first stage. ? If there is positive response to the brief screening tools, Edinburgh Postnatal Depression Scale should be used for further screening • For mild to moderate perinatal depression, psychotherapy, e.g (...) • chronic diseases • obesity • chronic pain (e.g. backache, headache) • impoverished home environment • financial constraint • experiencing major life changes • pregnant or postpartum period • socially-isolated • multiple vague symptoms • sleep disturbance • substance abuse (e.g. alcohol, illicit drugs) • loss of interest in sexual activity • old age • There is insufficient evidence to perform screening for depression in the general population. The common tools used in Malaysia for screening

2019 Ministry of Health, Malaysia

119. Incorporating Recognition and Management of Perinatal Depression Into Pediatric Practice

in adolescent and adult women using a validated tool, additional screening for depression is specifically recommended in the postpartum period. The 2017 Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, Fourth Edition recommendations from the AAP also now include screening for maternal depression by the 1-, 2-, 4-, and 6-month well-child visits. On the state level, health care providers, academic centers, Medicaid programs, legislatures, and local professional bodies (...) , including AAP chapters, have been working for decades to incorporate maternal perinatal depression screening with standardized tools into prenatal, postpartum, and periodic well-child visits. Ideally, screening would be conducted within a system of care that also provides access to additional mental health evaluation and treatment when concerns are identified. Although such interdisciplinary integration is not always available or feasible, progress has been made. New Jersey and Illinois (2008) were

2019 American Academy of Pediatrics

120. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts

to pharmacotherapy and complementary and alternative treatments. 3 For child and adolescent populations only, the guideline also examines the efficacy of medications, but because other existing guidelines adequately address this for adults, the panel chose not to review this body of evidence. The guideline then addresses harms and burdens of treatment and patient 4 values and preferences. The reviews on which this guideline is based did not specifically address screening for 1 Note that psychotic depression (...) Evidence- Based Practice Center scientists (Gartlehner et al., 2015). The panel supplemented this to fill in APA GUIDELINE FOR THE TREATMENT OF DEPRESSION ES-5 gaps of information with data from several others reviews that met quality criteria based on either an AMSTAR (A Measurement Tool to Assess Systematic Reviews; an instrument used to evaluate systematic reviews and meta-analyses for quality; Shea et al., 2007) review (Cuijpers, Driessen, et al., 2012a; Cuijpers, Koole, et al., 2014b; Cuijpers et

2019 American Psychological Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>